...
【24h】

Lawsone dimerization in cobalt(III) complexes toward the design of New prototypes of bioreductive prodrugs

机译:钴(III)配合物中的劳森酮二聚化,可用于设计新的生物还原性前药原型

获取原文
获取原文并翻译 | 示例

摘要

Dimerization of lawsone occurs upon reaction with Co(BF_4) _2·6H_2O and N,N′-bis(pyridin-2-ylmethyl) ethylenediamine (py_2en) to produce the mononuclear complex [Co ~(III)(bhnq)(py_2en)]BF_4·H_2O (1). This complex has been investigated as a prototype of a bioreductive prodrug, where the bhnq~(2-) ligand acts as a model for cytotoxic naphthoquinones. Cyclic voltammetry data in aqueous solution have shown a quasi-reversible Co~(III)/Co~(II) process at E_(1/2) = -0.26 V vs Fc/Fc~+. Reactivity studies revealed the dissociation of bhnq~(2-) from the complex upon reduction of 1 with ascorbic acid, and a dependence of the reaction rate on the oxygen concentration suggests the occurrence of redox cycling.
机译:与Co(BF_4)_2·6H_2O和N,N'-双(吡啶-2-基甲基)乙二胺(py_2en)反应生成单核配合物[Co〜(III)(bhnq)(py_2en)] BF_4·H_2O(1)。已经对该复合物作为生物还原性前药的原型进行了研究,其中bhnq〜(2-)配体充当细胞毒性萘醌的模型。水溶液中的循环伏安数据表明,在E_(1/2)= -0.26 V vs. Fc / Fc〜+时,准可逆的Co〜(III)/ Co〜(II)过程。反应性研究表明,用抗坏血酸还原1后,bhnq〜(2-)从复合物中解离,反应速率对氧浓度的依赖性表明氧化还原循环的发生。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号